Amicus Therapeutics (FOLD) Competitor Comparison
We are evaluating the key criteria listed to compare Amicus Therapeutics (FOLD) against its competitors in the Biotechnology industry.
Market Capitalization
43 / 368Gross Profits
22 / 278Total Revenue
30 / 300EBITDA
206 / 337Free Cashflow
273 / 352Quick Ratio
288 / 357Earnings per Share
71 / 359Dividend yield
0 / 6Total Cash
118 / 358Performance 3 years
109 / 368Performance 5 years
120 / 368Performance 10 years
80 / 368Linearity 3 years
34 / 368Linearity 5 years
2 / 368Linearity 10 years
29 / 367Total Rank
288 / 368Dividend Rank
348 / 368Valuation Rank
261 / 368Piotroski Rank
255 / 368Muliplier Rank
266 / 368Market Capitalization - FOLD ranking 43 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.